TOP-5 Price Targets of Analysts on July 11, 2025
Reading Time: 3 minutes
LifeMD [US53216B1044] Lake Street reaffirms Buy rating and raises price target from $12 to $18 (50% upside potential) LifeMD is building a technology-driven virtual health platform that covers various areas such as primary care, weight management, hormone therapy, men's and women's health, and mental health. According to analysts, the platform appears to scale efficiently and shows a promising track record. Additionally, the company fosters close relationships with pharmaceutical giants Eli Lilly and Novo Nordisk, which is viewed as a strategic...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
